AN2 Therapeutics, Inc. ( ANTX) - Stock Earnings
ANTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -9.4 million USD | — USD |
| 2025Q4 | -8.7 million USD | — USD |
| 2026Q1 | -10.0 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ANTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -64.7 million USD | — USD |
| 2024 | -51.3 million USD | — USD |
| 2025 | -35.2 million USD | — USD |
| 2026 Est. | — | — |
ANTX
Price: $4.76
52 week price:
Earnings Per Share: -1.10 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 47599
Market Capitalization: 119.5 million